Clinical Trials
2 trialsNCT02558387 2015-11-20
Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck
Samsung Medical Center
Phase 2 Unknown
NCT02278978 2015-05-12
BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma
National Taiwan University Hospital
Phase 2 Unknown